BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tellez-Gabriel M, Knutsen E, Perander M. Current Status of Circulating Tumor Cells, Circulating Tumor DNA, and Exosomes in Breast Cancer Liquid Biopsies. Int J Mol Sci 2020;21:E9457. [PMID: 33322643 DOI: 10.3390/ijms21249457] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Duque G, Manterola C, Otzen T, Arias C, Palacios D, Mora M, Galindo B, Holguín JP, Albarracín L. Cancer Biomarkers in Liquid Biopsy for Early Detection of Breast Cancer: A Systematic Review. Clin Med Insights Oncol 2022;16:117955492211348. [DOI: 10.1177/11795549221134831] [Reference Citation Analysis]
2 Zhong X, Chen L, Xu X, Liu Y, Tao F, Zhu M, Li C, Zhao D, Yang G, Chen J. Berberine as a potential agent for breast cancer therapy. Front Oncol 2022;12:993775. [DOI: 10.3389/fonc.2022.993775] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Freitas AJAD, Causin RL, Varuzza MB, Calfa S, Hidalgo Filho CMT, Komoto TT, Souza CDP, Marques MMC. Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer. IJMS 2022;23:9952. [DOI: 10.3390/ijms23179952] [Reference Citation Analysis]
4 Cardinali B, De Luca G, Tasso R, Coco S, Garuti A, Buzzatti G, Sciutto A, Arecco L, Villa F, Carli F, Reverberi D, Quarto R, Dono M, Del Mastro L. Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer. IJMS 2022;23:6320. [DOI: 10.3390/ijms23116320] [Reference Citation Analysis]
5 O’brien SR, Edmonds CE, Katz D, Mankoff DA, Pantel AR. 18F-Fluoroestradiol (FES) PET/CT: review of current practice and future directions. Clin Transl Imaging. [DOI: 10.1007/s40336-022-00494-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wu HJ, Chu PY. Current and Developing Liquid Biopsy Techniques for Breast Cancer. Cancers (Basel) 2022;14:2052. [PMID: 35565189 DOI: 10.3390/cancers14092052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Brothwell MRS, Barnett GC. Cancer Genetics and Genomics - Part 2. Clin Oncol (R Coll Radiol) 2022:S0936-6555(22)00098-X. [PMID: 35361559 DOI: 10.1016/j.clon.2022.02.014] [Reference Citation Analysis]
8 Mio C, Damante G. Challenges in promoter methylation analysis in the new era of translational oncology: a focus on liquid biopsy. Biochim Biophys Acta Mol Basis Dis 2022;1868:166390. [PMID: 35296416 DOI: 10.1016/j.bbadis.2022.166390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ashrafizadeh M, Kumar A, Aref AR, Zarrabi A, Mostafavi E. Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic Complications. IJN 2022;Volume 17:1229-53. [DOI: 10.2147/ijn.s350250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Hong R, Sun H, Li D, Yang W, Fan K, Liu C, Dong L, Wang G. A Review of Biosensors for Detecting Tumor Markers in Breast Cancer. Life 2022;12:342. [DOI: 10.3390/life12030342] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ghauri MA, Raza A, Hayat U, Atif N, Iqbal HMN, Bilal M. Mechanistic insights expatiating the biological role and regulatory implications of estrogen and HER2 in breast cancer metastasis. Biochim Biophys Acta Gen Subj 2022;1866:130113. [PMID: 35202768 DOI: 10.1016/j.bbagen.2022.130113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Di Agostino S, Vahabi M, Turco C, Fontemaggi G. Secreted Non-Coding RNAs: Functional Impact on the Tumor Microenvironment and Clinical Relevance in Triple-Negative Breast Cancer. ncRNA 2022;8:5. [DOI: 10.3390/ncrna8010005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
13 Buentzel J, Klemp HG, Kraetzner R, Schulz M, Dihazi GH, Streit F, Bleckmann A, Menck K, Wlochowitz D, Binder C. Metabolomic Profiling of Blood-Derived Microvesicles in Breast Cancer Patients. Int J Mol Sci 2021;22:13540. [PMID: 34948336 DOI: 10.3390/ijms222413540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Bari SMI, Hossain FB, Nestorova GG. Advances in Biosensors Technology for Detection and Characterization of Extracellular Vesicles. Sensors (Basel) 2021;21:7645. [PMID: 34833721 DOI: 10.3390/s21227645] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Lv W, Wang Y, Zhao C, Tan Y, Xiong M, Yi Y, He X, Ren Y, Wu Y, Zhang Q. Identification and Validation of m6A-Related lncRNA Signature as Potential Predictive Biomarkers in Breast Cancer. Front Oncol 2021;11:745719. [PMID: 34722303 DOI: 10.3389/fonc.2021.745719] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
16 Cui R, Wang C, Li T, Hua J, Zhao T, Ren L, Wang Y, Li Y. Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancer. Cancer Cell Int 2021;21:571. [PMID: 34711246 DOI: 10.1186/s12935-021-02256-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Honoré N, Galot R, van Marcke C, Limaye N, Machiels JP. Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact. Cancers (Basel) 2021;13:5364. [PMID: 34771526 DOI: 10.3390/cancers13215364] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
18 Cafforio P, Palmirotta R, Lovero D, Cicinelli E, Cormio G, Silvestris E, Porta C, D'Oronzo S. Liquid Biopsy in Cervical Cancer: Hopes and Pitfalls. Cancers (Basel) 2021;13:3968. [PMID: 34439120 DOI: 10.3390/cancers13163968] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
19 González-Conde M, Yañez-Gómez C, López-López R, Costa C. Liquid Biopsy: A New Tool for Overcoming CDKi Resistance Mechanisms in Luminal Metastatic Breast Cancer. J Pers Med 2021;11:407. [PMID: 34068388 DOI: 10.3390/jpm11050407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Jongbloed EM, Deger T, Sleijfer S, Martens JWM, Jager A, Wilting SM. A Systematic Review of the Use of Circulating Cell-Free DNA Dynamics to Monitor Response to Treatment in Metastatic Breast Cancer Patients. Cancers (Basel) 2021;13:1811. [PMID: 33920135 DOI: 10.3390/cancers13081811] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]